IRIS Accounts Production v23.3.1.45 10229187 director 1.7.22 30.6.23 30.6.23 false true false false true false Ordinary 1.00000 iso4217:GBPiso4217:USDiso4217:EURxbrli:sharesxbrli:pureutr:tonnesutr:kWh102291872022-06-30102291872023-06-30102291872022-07-012023-06-30102291872021-06-30102291872021-07-012022-06-30102291872022-06-3010229187ns10:Originalns15:EnglandWales2022-07-012023-06-3010229187ns14:PoundSterlingns10:Original2022-07-012023-06-3010229187ns10:Originalns10:Director12022-07-012023-06-3010229187ns10:Original2022-07-012023-06-3010229187ns10:Original2023-06-3010229187ns10:Originalns10:PrivateLimitedCompanyLtd2022-07-012023-06-3010229187ns10:Originalns10:SmallEntities2022-07-012023-06-3010229187ns10:Originalns10:AuditExempt-NoAccountantsReport2022-07-012023-06-3010229187ns10:Originalns10:SmallCompaniesRegimeForDirectorsReport2022-07-012023-06-3010229187ns10:SmallCompaniesRegimeForAccountsns10:Original2022-07-012023-06-3010229187ns10:Originalns10:FullAccounts2022-07-012023-06-3010229187ns10:Originalns10:OrdinaryShareClass12022-07-012023-06-3010229187ns10:Originalns10:RegisteredOffice2022-07-012023-06-3010229187ns10:Original2022-06-3010229187ns10:Originalns5:CurrentFinancialInstruments2023-06-3010229187ns10:Originalns5:CurrentFinancialInstruments2022-06-3010229187ns10:Originalns5:Non-currentFinancialInstruments2023-06-3010229187ns10:Originalns5:Non-currentFinancialInstruments2022-06-3010229187ns5:ShareCapitalns10:Original2023-06-3010229187ns5:ShareCapitalns10:Original2022-06-3010229187ns10:Originalns5:RetainedEarningsAccumulatedLosses2023-06-3010229187ns10:Originalns5:RetainedEarningsAccumulatedLosses2022-06-3010229187ns10:Originalns5:PlantMachinery2022-07-012023-06-3010229187ns10:Originalns5:FurnitureFittings2022-07-012023-06-3010229187ns10:Originalns5:ComputerEquipment2022-07-012023-06-3010229187ns10:Original2021-07-012022-06-3010229187ns10:Originalns5:PlantMachinery2022-06-3010229187ns10:Originalns5:FurnitureFittings2022-06-3010229187ns10:Originalns5:ComputerEquipment2022-06-3010229187ns10:Original2022-06-3010229187ns10:Originalns5:PlantMachinery2023-06-3010229187ns10:Originalns5:FurnitureFittings2023-06-3010229187ns10:Originalns5:ComputerEquipment2023-06-3010229187ns10:Originalns5:PlantMachinery2022-06-3010229187ns10:Originalns5:FurnitureFittings2022-06-3010229187ns10:Originalns5:ComputerEquipment2022-06-3010229187ns10:Originalns5:CurrentFinancialInstrumentsns5:WithinOneYear2023-06-3010229187ns10:Originalns5:CurrentFinancialInstrumentsns5:WithinOneYear2022-06-3010229187ns10:Originalns10:OrdinaryShareClass12023-06-3010229187ns10:Originalns5:RetainedEarningsAccumulatedLosses2022-06-3010229187ns10:Originalns5:RetainedEarningsAccumulatedLosses2022-07-012023-06-30
REGISTERED NUMBER: 10229187 (England and Wales)















Financial Statements for the Year Ended 30 June 2023

for

KO BLOODLINE LIMITED

KO BLOODLINE LIMITED (REGISTERED NUMBER: 10229187)






Contents of the Financial Statements
for the Year Ended 30 June 2023




Page

Company Information 1

Balance Sheet 2

Notes to the Financial Statements 4


KO BLOODLINE LIMITED

Company Information
for the Year Ended 30 June 2023







DIRECTOR: Mr P Marut





REGISTERED OFFICE: 2nd Floor
156 Lower Clapton Road
London
E5 0QJ





REGISTERED NUMBER: 10229187 (England and Wales)





ACCOUNTANTS: THB LLP
1 & 2 Studley Court Mews
Studley Court
Guildford Road
Chobham
Surrey
GU24 8EB

KO BLOODLINE LIMITED (REGISTERED NUMBER: 10229187)

Balance Sheet
30 June 2023

30/6/23 30/6/22
Notes £    £    £    £   
FIXED ASSETS
Tangible assets 4 22,682 26,540

CURRENT ASSETS
Debtors 5 - 1,872
Cash at bank 39,544 47,191
39,544 49,063
CREDITORS
Amounts falling due within one year 6 25,541 19,112
NET CURRENT ASSETS 14,003 29,951
TOTAL ASSETS LESS CURRENT
LIABILITIES

36,685

56,491

CREDITORS
Amounts falling due after more than one
year

7

26,666

31,110
NET ASSETS 10,019 25,381

CAPITAL AND RESERVES
Called up share capital 8 1 1
Retained earnings 9 10,018 25,380
SHAREHOLDERS' FUNDS 10,019 25,381

The company is entitled to exemption from audit under Section 477 of the Companies Act 2006 for the year ended 30 June 2023.

The members have not required the company to obtain an audit of its financial statements for the year ended 30 June 2023 in accordance with Section 476 of the Companies Act 2006.

The director acknowledges his responsibilities for:
(a)ensuring that the company keeps accounting records which comply with Sections 386 and 387 of the Companies Act 2006 and
(b)preparing financial statements which give a true and fair view of the state of affairs of the company as at the end of each financial year and of its profit or loss for each financial year in accordance with the requirements of Sections 394 and 395 and which otherwise comply with the requirements of the Companies Act 2006 relating to financial statements, so far as applicable to the company.

KO BLOODLINE LIMITED (REGISTERED NUMBER: 10229187)

Balance Sheet - continued
30 June 2023


The financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

In accordance with Section 444 of the Companies Act 2006, the Income Statement has not been delivered.

The financial statements were approved by the director and authorised for issue on 6 March 2024 and were signed by:





Mr P Marut - Director


KO BLOODLINE LIMITED (REGISTERED NUMBER: 10229187)

Notes to the Financial Statements
for the Year Ended 30 June 2023

1. STATUTORY INFORMATION

KO Bloodline Limited is a private company, limited by shares , registered in England and Wales. The company's registered number and registered office address can be found on the Company Information page.

The presentation currency of the financial statements is the Pound Sterling (£).


2. ACCOUNTING POLICIES

Basis of preparing the financial statements
These financial statements have been prepared in accordance with Financial Reporting Standard 102 "The Financial Reporting Standard applicable in the UK and Republic of Ireland" including the provisions of Section 1A "Small Entities" and the Companies Act 2006. The financial statements have been prepared under the historical cost convention.

Turnover
Turnover is measured at the fair value of the consideration received or receivable, excluding discounts, rebates, value added tax and other sales taxes.

Tangible fixed assets
Depreciation is provided at the following annual rates in order to write off each asset over its estimated useful life.
Gym equipment - 15% on reducing balance
Office equipment - 25% on cost
Computer equipment - 33% on cost

Taxation
Taxation for the year comprises current tax. Tax is recognised in the Income Statement, except to the extent that it relates to items recognised in other comprehensive income or directly in equity.

Current taxation assets and liabilities are not discounted.

Current tax is recognised at the amount of tax payable using the tax rates and laws that have been enacted or substantively enacted by the balance sheet date.

Hire purchase and leasing commitments
Rentals paid under operating leases are charged to profit or loss on a straight line basis over the period of the lease.

Pension costs and other post-retirement benefits
The company operates a defined contribution pension scheme. Contributions payable to the company's pension scheme are charged to profit or loss in the period to which they relate.

3. EMPLOYEES AND DIRECTORS

The average number of employees during the year was 1 (2022 - 1 ) .

KO BLOODLINE LIMITED (REGISTERED NUMBER: 10229187)

Notes to the Financial Statements - continued
for the Year Ended 30 June 2023

4. TANGIBLE FIXED ASSETS
Gym Office Computer
equipment equipment equipment Totals
£    £    £    £   
COST
At 1 July 2022 27,014 1,580 12,415 41,009
Additions 3,098 675 391 4,164
At 30 June 2023 30,112 2,255 12,806 45,173
DEPRECIATION
At 1 July 2022 6,868 903 6,698 14,469
Charge for year 3,303 521 4,198 8,022
At 30 June 2023 10,171 1,424 10,896 22,491
NET BOOK VALUE
At 30 June 2023 19,941 831 1,910 22,682
At 30 June 2022 20,146 677 5,717 26,540

5. DEBTORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
30/6/23 30/6/22
£    £   
Trade debtors - 1,872

6. CREDITORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
30/6/23 30/6/22
£    £   
Bank loans and overdrafts 4,444 4,444
Taxation and social security 20,767 14,338
Other creditors 330 330
25,541 19,112

7. CREDITORS: AMOUNTS FALLING DUE AFTER MORE THAN ONE
YEAR
30/6/23 30/6/22
£    £   
Bank loans 26,666 31,110

Amounts falling due in more than five years:

Repayable by instalments
Bank loans more 5 yr by instal 8,889 13,333

8. CALLED UP SHARE CAPITAL

Allotted, issued and fully paid:
Number: Class: Nominal 30/6/23 30/6/22
value: £    £   
1 Ordinary £1 1 1

KO BLOODLINE LIMITED (REGISTERED NUMBER: 10229187)

Notes to the Financial Statements - continued
for the Year Ended 30 June 2023

9. RESERVES
Retained
earnings
£   

At 1 July 2022 25,380
Profit for the year 23,138
Dividends (38,500 )
At 30 June 2023 10,018